a developer of novel antibodies
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VRSCX | 24.70 | 0.15 | +0.61% |
Voya SmallCap Opportunities Port R6 | |||
UBVVX | 91.17 | 0.46 | +0.51% |
Undiscovered Managers Behavioral Val R5 | |||
RLGYX | 10.78 | N/A | N/A |
Russell Inv Global Equity Y | |||
TCSHX | 14.48 | N/A | N/A |
Transamerica Multi-Asset Income C | |||
GCSVX | 10.70 | N/A | N/A |
Geneva SMID Cap Growth Institutional |
A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with PEPG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then PEPG could also see price increases.
Ticker / NAME | Correlation To PRTA | 1D Price Change % | ||
---|---|---|---|---|
PRTA | 100% | +2.49% | ||
PEPG - PRTA | 53% Loosely correlated | -1.57% | ||
BEAM - PRTA | 51% Loosely correlated | -3.16% | ||
DNLI - PRTA | 50% Loosely correlated | +0.33% | ||
NAUT - PRTA | 49% Loosely correlated | +4.46% | ||
RGNX - PRTA | 46% Loosely correlated | +0.73% | ||
More |